High seroconversion rate but low antibody titers after two injections of BNT162b2 (Pfizer-BioNTech) vaccine in patients treated with chemotherapy for solid cancers

Ann Oncol. 2021 Oct;32(10):1294-1295. doi: 10.1016/j.annonc.2021.06.018. Epub 2021 Jun 22.
No abstract available

Publication types

  • Letter

MeSH terms

  • BNT162 Vaccine
  • COVID-19 Vaccines
  • COVID-19*
  • Humans
  • Neoplasms* / drug therapy
  • Seroconversion
  • Vaccines*

Substances

  • COVID-19 Vaccines
  • Vaccines
  • BNT162 Vaccine